Detalhe da pesquisa
1.
Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.
Br J Cancer
; 106(8): 1406-14, 2012 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22491422
2.
Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells.
Curr Mol Med
; 10(7): 674-91, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20712585